STAQ Pharma
Bringing Safety, Transparency, Availability, and Quality to Outsourced Medications
STAQ Pharma, a hospital-owned 503B outsourcing supplier committed to alleviating drug shortages, announced the launch of their oncology portfolio at a ceremony held at their Columbus, OH, facility on Friday, July 26.
STAQ Pharma Honored with the Prestigious 2024 Heartbeat of Healthcare Supplier Award Denver, CO – March 6, 2024 – STAQ Pharma, a leading 503B Outsourcing Facility, is pleased to announce its selection of the prestigious 2024 Heartbeat of Healthcare Supplier Award. This accolade was presented to STAQ Pharma’s leadership team during the Federation of American
STAQ Pharma is working with the nonprofit scientific research organization IAVI to provide support services for the production of an innovative intranasal spray targeting COVID-19. This multi-partner project aims to produce a miniprotein anti-viral blocker delivered via an intranasal device. STAQ Pharma's expertise in aseptic processing and experience with similar devices make them a key player in this project.
On October 5th, several members of the Columbus community, including STAQ employees and Board of Directors celebrated the grand opening of STAQ Pharma’s newest location in Columbus, Ohio. Read more from RX Insider.
An ongoing shortage of albuterol, a critical medicine for treating breathing problems, has intensified following the shutdown of a major supplier to U.S. hospitals. STAQ Pharma, a hospital-owned 503B outsourcing supplier, has been instrumental in addressing this crisis by producing compounded pediatric albuterol medications to meet the needs of children’s hospitals. As supply chain issues
With February’s sudden shutdown of an Illinois manufacturing plant, STAQ’s production of Albuterol may be in even higher demand, according to a recent article by The Washington Post.
Albuterol — one of the most essential medications for pediatric patients — has been facing a critical shortage since June 2022. In partnership with Children’s Hospital Colorado (CHC), STAQ has been able to supply and maintain continuous albuterol for children’s hospitals. STAQ is committed to getting pediatric hospitals through this respiratory season and helping to
Being able to make a positive impact on the critical Albuterol shortage is one of the reasons we got into this business. The “A” in STAQ stands for availability, after all.
The results of STAQ’s partnership with Angels for Change to address shortages of two critical medications for children are not going unnoticed. Watch CNN’s powerful story and/or read the article here.
As a direct result of STAQ’s partnership with Angels for Change, in just the first 6 months, more than 500,000 pediatric patients have had been protected from a shortage of Potassium Chloride (KCl) and 23.4% Sodium Chloride (NaCL). Read the full story.
As part of its partnership with Angels for Change, STAQ Pharma has been producing critically-needed medications for pediatric patients as part of a new program called projectPROTECT. Watch the full video (just under 7 minutes) now.
“STAQ Pharma is committed to supporting hospital pharmacies with their medication needs to care for their patients. We are honored to be chosen by Angels for Change and the Children’s Hospital Association to address this critical shortage situation,” said Mark Spiecker, president of STAQ Pharma. Read the full story.
In partnership with Children’s Hospital Colorado, STAQ has launched pre-filled, pediatric concentrations and doses of several important sterile compounded medications widely used in pediatric hospitals. Read the full article here.
Each year, the Colorado BioScience Association (CBSA) celebrates the companies and organizations driving new health innovations to save and change lives around the world. On December 10, 2020, STAQ was named a Finalist for company of the year, becoming one of just two companies among 720 to receive this honor.
STAQ’s co-founder and CEO, Joe Bagan, has some exciting things to say about the growth and future of 503Bs. Read the full story as profiled by Company this week.
For the past 13 years, Pharmacy Purchasing & Products magazine has devoted its April issue to the State of Compounding. “STAQ is honored to be nationally ranked as a top 503b facility for 2020,” said Mark Spiecker, President. “Having only recently opened our doors, we look forward to serving even more of you and becoming your trusted
The Colorado Office of Economic Development and International Trade awarded STAQ an early stage retention grant in support of its innovative technologies and creation of viable products that help advance the state’s key industries. STAQ was acknowledged for being the first in its industry to develop and deploy robotic syringe filling in compounded medications.
The Associated General Contractors (AGC) named Murphy Company the 2019 Jack Mincher Specialty Contractwinner for Meeting the Challenge of a Difficult Project. Read the full story
ENR Mountains States named Turner Construction and STAQ Pharma a merit award winner for 2019 Best Small Project (under $10M).
